As organizations race to adopt artificial intelligence, the conversation has increasingly shifted from raw model performance ...

Every year, bacteria kill more than a million people worldwide through infections that no longer respond to antibiotics. In ...

Recursion harnesses AI for large-scale drug discovery, while Summit's betting on a single oncology candidate. How do their ...

How Recursion is leading a new era of AI-driven drug discovery AI drug discovery is not a new phenomenon – but it is evolving at an almost dizzying pace. Recursion is one of the earliest innovators in ...

While there have been many sober warnings about AI and recursive self-improvement, Arianna Huffington argues that it is a ...

Autonomous AI post-training reached frontier scale for the first time: NVIDIA researchers published a paper showing an AI ...

On Wednesday, OpenAI took its biggest step yet towards full technological independence with the unveiling of a new AI chip, ...

The most capable one didn't make the cut.

Multiple milestones achieved or on track across wholly owned and partnered programs REC-1245 (RBM39 degrader): Early clinical data in solid tumors demonstrate a well-tolerated safety profile and ...

Abstract: This paper presents a hierarchical power allocation method (HPAM) for dual-stack fuel cell (FC) hybrid locomotive powertrain. In a high-power FC application such as rail transportation, the ...

AI thrives on data but feeding it the right data is harder than it seems. As enterprises scale their AI initiatives, they face the challenge of managing diverse data pipelines, ensuring proximity to ...